Clinical Trials: Evaluating Genetic Risk Factors for Childhood-onset Schizophrenia

Article

This study will evaluate familial risk factors for schizophrenia.

Study Type:

Observational

Age/Gender Requirements:

6 years+ (male/female)

Sponsor:

National Institute of Mental Health

Purpose:

Building on earlier research, the current study will evaluate familial risk factors for schizophrenia, including psychiatric diagnoses of family members, smooth pursuit eye movements, and neuropsychological test deficits.

Click here to access this third-party resource.

Related Videos
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
© 2024 MJH Life Sciences

All rights reserved.